BBIO
USDBridgeBio Pharma Inc. Common Stock
실시간 가격
가격 차트
핵심 지표
시장 지표
시가
$61.420
고가
$61.905
저가
$60.230
거래량
2.10M
기업 기본 정보
시가총액
11.8B
산업
생명공학
국가
United States
거래 통계
평균 거래량
2.63M
거래소
NMS
통화
USD
52주 범위
관련 뉴스
BridgeBio to Participate in November Investor Conferences
PALO ALTO, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (NASDAQ:BBIO) ("BridgeBio" or the "Company"), a new type of biopharmaceutical company focused on genetic diseases, today announced that
BridgeBio to Present Data from the Overall ATTR-CM Variant and V142I (V122I) Populations from ATTRibute-CM at the AHA Scientific Sessions 2025
PALO ALTO, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (NASDAQ:BBIO) ("BridgeBio" or the "Company"), a new type of biopharmaceutical company focused on genetic diseases, announced today that ten
HC Wainwright & Co. Reiterates Buy on BridgeBio Pharma, Maintains $90 Price Target
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates BridgeBio Pharma with a Buy and maintains $90 price target.
Goldman Sachs Maintains Buy on BridgeBio Pharma, Raises Price Target to $100
Goldman Sachs analyst Paul Choi maintains BridgeBio Pharma with a Buy and raises the price target from $55 to $100.
TD Cowen Maintains Buy on BridgeBio Pharma, Raises Price Target to $95
TD Cowen analyst Tyler Van Buren maintains BridgeBio Pharma with a Buy and raises the price target from $60 to $95.
Raymond James Reiterates Outperform on BridgeBio Pharma, Raises Price Target to $71
Raymond James analyst Martin Auster reiterates BridgeBio Pharma with a Outperform and raises the price target from $69 to $71.
Cantor Fitzgerald Maintains Overweight on BridgeBio Pharma, Raises Price Target to $110
Cantor Fitzgerald analyst Josh Schimmer maintains BridgeBio Pharma with a Overweight and raises the price target from $100 to $110.
